DELAFIELD, Wis. (Stockpickr) -- As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Tilly's

  • Thursday's Range: $7.74-$8.20
  • 52-Week Range: $6.65-$16.99
  • Thursday's Volume: 36,000
  • Three-Month Average Volume: 120,050

Tilly's  (TLYS) retails casual clothing, footwear and accessories for teens and young adults in the U.S. This stock is trading up 7% to $8.19 in Thursday's trading session.

From a technical perspective, Tilly's is ripping sharply higher here right above some near-term support at $7.46 with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares founding buying interest at $7.54 to $7.46 a share. Following that bottom, shares of Tilly's have now started to jump sharply higher and it's quickly moving within range of triggering a major breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $8.39 to $8.53 and then once it clears its 50-day moving average of $8.80 with high volume.

Traders should now look for long-biased trades in Tilly's as long as it's trending above Thursday's intraday low of $7.73 or above those double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 120,050 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.50 to $9.71, or even $10.15 to $10.35 a share.

 



CorMedix

  • Thursday's Range: $2.88-$3.00
  • 52-Week Range: $1.25-$10.40
  • Thursday's Volume: 171,000
  • Three-Month Average Volume: 691,997

CorMedix  (CRMD) , a pharmaceutical company, intends to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. This stock is trading up 5.2% to $3.02 in Thursday's trading session.

From a technical perspective, CorMedix is ripping sharply higher here right above some near-term support at $2.68 with lighter-than-average volume. This stock has been uptrending a bit over the last few weeks, with shares moving higher from its low of $2.41 to its recent high of $3.07. During that uptrend, shares of CorMedix have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed this stock within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.08 to $3.10 and then once it clears its 50-day moving average of $3.14 with high volume.

Traders should now look for long-biased trades in CorMedix as long as it's trending above some near-term support at $2.68 and then once it sustains a move or close above those breakout levels with volume that hits near or above 691,997 shares. If that breakout gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3.50 to $3.76, or even $4 to $4.31 a share.


TrueCar

  • Thursday's Range: $5.94-$6.19
  • 52-Week Range: $4.01-$24.71
  • Thursday's Volume: 365,000
  • Three-Month Average Volume: 1.60 million

TrueCar  (TRUE) operates as an Internet-based information, technology and communication services company. This stock is trading up 3.6% to $6.19 Thursday's trading session.

From a technical perspective, TrueCar is trending notably higher here right above some near-term support levels at its 20-day moving average of $5.64 to $5.50 with lighter-than-average volume. This stock recently formed a double bottom chart pattern, after shares of TrueCar found buying interest at $5.56 to $5.50. Following that bottom, shares of TrueCar have now started to spike higher and it's quickly moving within range of triggering a major breakout trade. That breakout will trigger if this stock manages to take out some near-term overhead resistance at $6.41 with high volume.

Traders should now look for long-biased trades in TrueCar as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above $6.41 with volume that hits near or above 1.60 million shares. If that breakout gets started soon, then this stock will set up to re-test or possibly take out its next major overhead resistance level at its 50-day moving average of $6.93 to $7.04, or even $7.50 a share. Any high-volume move above $7.50 will then give shares of TrueCar a chance to re-fill some of its previous gap-down-day zone from July that started above $11 a share.

Oncothyreon

  • Thursday's Range: $3.30-$3.57
  • 52-Week Range: $1.41-$4.69
  • Thursday's Volume: 596,000
  • Three-Month Average Volume: 1.19 million

Oncothyreon  (ONTY) , a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. This stock is trading up 6% to $3.52 in Thursday's trading session.

From a technical perspective, Oncothyreon is ripping sharply higher here right off its 20-day moving average of $3.34 with decent upside volume flows. This stock recently formed a double bottom chart pattern, after shares found buying interest at $3.22 to $3.23 a share. Following that bottom, shares of Oncothyreon have now started to trend to the upside and move back above both its 20-day and 50-day moving averages. That trend is now quickly pushing this stock within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.65 to $3.72 with high volume.

Traders should now look for long-biased trades in Oncothyreon as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that registers near or above 1.19 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4.02 to $4.12, or even its 52-week high of $4.69 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Opinion

Microsoft's Earnings Provide Fresh Proof That the LinkedIn Deal Is Paying Off

Microsoft's Earnings Provide Fresh Proof That the LinkedIn Deal Is Paying Off

Bitcoin Prices Are Back Up, but Traditional Investors Remain Skeptical

Bitcoin Prices Are Back Up, but Traditional Investors Remain Skeptical

Microsoft Pops on Strong Earnings and Guidance: 8 Key Takeaways

Microsoft Pops on Strong Earnings and Guidance: 8 Key Takeaways

EBay's Soft Guidance Doesn't Reflect Well on its Attempts to Fight Off Amazon

EBay's Soft Guidance Doesn't Reflect Well on its Attempts to Fight Off Amazon

4 Key Takeaways for Apple, Nvidia and Others From TSMC's Earnings Report

4 Key Takeaways for Apple, Nvidia and Others From TSMC's Earnings Report